Helius Medical Technologies (NASDAQ:HSDT) Posts Quarterly Earnings Results, Misses Estimates By $0.09 EPS

Helius Medical Technologies (NASDAQ:HSDT) released its quarterly earnings data on Tuesday. The company reported ($1.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.94) by ($0.09), Zacks reports. The business had revenue of $0.15 million during the quarter, compared to analysts’ expectations of $0.10 million. Helius Medical Technologies had a negative return on equity of 244.82% and a negative net margin of 1,764.74%.

Helius Medical Technologies Stock Performance

NASDAQ HSDT opened at $0.44 on Wednesday. The company has a market cap of $1.62 million, a PE ratio of -0.07 and a beta of 1.62. The firm’s 50 day moving average price is $0.56 and its 200-day moving average price is $0.60. Helius Medical Technologies has a 52-week low of $0.37 and a 52-week high of $7.19.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.